1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL CANCER DIAGNOSTICS MARKET BY DIAGNOSTICS PROCEDURES
5.1. Introduction
5.2. Laboratory Test
5.3. Imaging Procedures
5.4. Bipsy
6. GLOBAL CANCER DIAGNOSTICS MARKET BY CANCER TYPE
6.1. Introduction
6.2. Lung cancer
6.3. Breast cancer
6.4. Colorectal Cancer
6.5. Skin Cancer
6.6. Stomach Cancer
6.7. Others
7. GLOBAL CANCER DIAGNOSTICS MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Clinics
7.4. Diagnostics Centers
8. GLOBAL CANCER DIAGNOSTICS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Diagnostic Procedures
8.2.2. By Cancer Type
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Diagnostic Procedures
8.3.2. By Cancer Type
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Diagnostic Procedures
8.4.2. By Cancer Type
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. Germany
8.4.4.2. France
8.4.4.3. United Kingdom
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Diagnostic Procedures
8.5.2. By Cancer Type
8.5.3. By End-User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Israel
8.5.4.4. Others
8.6. Asia Pacific
8.6.1. By Diagnostic Procedures
8.6.2. By Cancer Type
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. China
8.6.4.2. India
8.6.4.3. Japan
8.6.4.4. South Korea
8.6.4.5. Indonesia
8.6.4.6. Thailand
8.6.4.7. Taiwan
8.6.4.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. bioMérieux SA
10.2. Roche Diagnostics
10.3. MetaCell
10.4. Breath Diagnostics, Inc
10.5. Metabiomics
10.6. Castle Biosciences, Inc.
10.7. Exact Sciences Corporation
10.8. Thermo Fisher Scientific Inc.
10.9. Abbott Laboratories
10.10. GE Healthcare
10.11. Siemens Healthineers (Siemens AG)
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES